EVS Broadcast Equipment publish a transparency notification
Publication on March 18, 2021, after market closing
Regulated information – transparency notification
EVS Broadcast Equipment S.A.: Euronext Brussels (EVS.BR), Bloomberg (EVS BB), Reuters (EVSB.BR)
Publication of a transparency notification
(Article 14, first paragraph, of the Law of 2 May 2007 on disclosure of major holdings)
On March 15, 2021, EVS Broadcast Equipment has received a transparency notification indicating that Otus Capital Management Limited now holds 3.10% of the voting rights of the company. Otus Capital Management Limited has therefore crossed up the threshold of 3%.
The notification, dated March 15, 2021, contains the following information:
Reason for the notification: acquisition or disposal of voting securities or voting rights
Notification by: A parent undertaking or a controlling person
Persons subject to the notification requirement: Otus Capital Management Limited, 29 Queen Anne’s Gate, London SW1H 9BU, UK; Andrew Gibbs
Transaction date: March 11, 2021
Threshold that is crossed (in %): 3%
|A) Voting rights||Previous notification||After the transaction|
|# voting rights||# voting rights||% voting rights|
|Holders of voting rights||Linked to securities||Not linked to the securities||Linked to securities||Not linked to the securities|
|Otus Capital Management Limited||443,868||3.10%|
|B) Equivalent financial instruments||After the transaction|
|Holders of equivalent financial instruments||Type of financial|
|Exercise period or date||# of voting rights that may be acquired if the instrument is exercised||% of voting rights||Settlement|
|TOTAL (A & B)||# voting rights||% of voting rights|
|TOTAL (A & B)||443,868||3.10%|
Full chain of controlled undertakings through which the holding is effectively held:
Otus Capital Management Ltd acts as the investment manager (with control of voting rights) for: the Maga Micro Cap Fund, Regents of the University of Michigan and LGT Select Equity Global-Pool Otus, that hold the shares reported here. Otus Capital Management Ltd is 100% owned by Andrew Gibbs.
This press release and the notification are available on the EVS website (www.evs.com).
Shareholders must declare their ownership in EVS shares as soon as their shareholding passes over/under the 3% threshold (required by Company Statutes) and any multiple of 5% thresholds (required by Belgian Law). Notifications of important shareholdings to be made according to the Law of May 2, 2007 and the EVS's bylaws, should be sent to the company (by email firstname.lastname@example.org or fax +32 4 361 7089) and to the FSMA. The current number of shares (denominator) to be taken into account is 14,327,024 shares.
We create return on emotion.
EVS is globally recognized as a leader in live video technology for broadcast and new media productions. Our passion and purpose are to help our clients craft immersive stories that trigger the best return on emotion. Through a wide range of products and solutions, we deliver the most gripping live sports images, buzzing entertainment shows and breaking news content to billions of viewers every day – and in real-time. The company is headquartered in Belgium with offices in Europe, the Middle East, Asia and North America, and provides sales and technical support to more than 100 countries.
EVS is a public company traded on Euronext Brussels: EVS, ISIN: BE0003820371.
For more information, please visit www.evs.com.
|For more information, please contact:|
Serge VAN HERCK*, CEO
EVS Broadcast Equipment S.A., Liege Science Park, 13 rue du Bois Saint-Jean, B-4102 Seraing, Belgium
Tel: +32 4 361 70 00. E-mail: email@example.com; www.evs.com
Représentant une BV
Forward Looking Statements
This press release contains forward-looking statements with respect to the business, financial condition, and results of operations of EVS and its affiliates. These statements are based on the current expectations or beliefs of EVS' management are subject to a number of risks and uncertainties that could cause actual results or performance of the Company to differ materially from those contemplated in such forward-looking statements. These risks and uncertainties relate to changes in technology and market requirements, the company's concentration on one industry, decline in demand for the company's products and those of its affiliates, inability to timely develop and introduce new technologies, products and applications, and loss of market share and pressure on pricing resulting from competition which could cause the actual results or performance of the company to differ materially from those contemplated in such forward-looking statements. EVS undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
Immunicum Announces Presentations at Upcoming Scientific Conferences in April and May19.4.2021 08:00:00 CEST | Press release
Press Release 19 April 2021 Immunicum Announces Presentations at Upcoming Scientific Conferences in April and May Immunicum AB (publ) today announced that it will participate and deliver multiple presentations featuring its proprietary Phase II clinical candidates, immune primer ilixadencel and cancer relapse vaccine DCP-001, at the following upcoming scientific conferences: Neoantigen Summit Europe, April 20 – 22, 2021 Alex Karlsson-Parra, Chief Scientific Officer at Immunicum, will make an oral presentation on “Harnessing the immune-priming function of allogeneic dendritic cells in neoantigen-based vaccines”, on Wednesday, April 21st at 2:45 pm CET / 8:45 am ET. Cancer Immunotherapy (CIMT) Annual Meeting, May 10 – 12, 2021. Alex Karlsson-Parra will deliver an oral presentation on “Combining intratumoral administration of inflammatory allogeneic DCs with systemic anti-CTLA-4 treatment leads to tumor eradication and is associated with peripheral expansion of CD8+ effector cells with a
Intervest starts construction works at Herentals Green Logistics19.4.2021 08:00:00 CEST | Press release
#TeamIntervest gives concrete shape to a sustainable cluster of 45.000 m² of offices and logistics. Attachment Development project Herentals
Immunicum tillkännager presentationer vid kommande vetenskapliga möten i april och maj19.4.2021 08:00:00 CEST | Pressemelding
Pressrelease 19 april 2021 Immunicum tillkännager presentationer vid kommande vetenskapliga möten i april och maj Immunicum AB (publ) meddelade idag att bolaget kommer att delta och göra ett flertal presentioner gällande sina två program i klinisk fas II-utveckling, immunprimern ilixadencel och canceråterfallsvaccinet DCP-001 vid nedanstående vetenskapliga möten: Neoantigen Summit Europe, 20 – 22 april, 2021 Alex Karlsson-Parra, Chief Scientific Officer, Immunicum håller ett anförande på temat ” “Harnessing the immune-priming function of allogeneic dendritic cells in neoantigen-based vaccines”, onsdagen den 21 april kl. 14.45 CET/8.45 ET. Cancer Immunotherapy (CIMT) Annual Meeting, 10-12 maj, 2021 Alex Karlsson-Parra, Chief Scientific Officer, Immunicum håller ett anförande på temat “Combining intratumoral administration of inflammatory allogeneic DCs with systemic anti-CTLA-4 treatment leads to tumor eradication and is associated with peripheral expansion of CD8+ effector cells with a
ABN AMRO accepted settlement offer in the anti-money laundering investigation in the Netherlands19.4.2021 07:30:00 CEST | Press release
ABN AMRO accepted settlement offer in the anti-money laundering investigation in the Netherlands Today ABN AMRO Bank N.V. (ABN AMRO) announced that it has accepted a settlement offer from the Dutch Public Prosecution Service (DPPS) in connection with the previously announced investigation by the DPPS into ABN AMRO's compliance with its obligations under the Dutch Anti-Money Laundering and Counter Terrorism Financing Act (Wet ter voorkoming van witwassenen financiering van terrorisme, AML/CTF Act) between 2014 and 2020. As part of this settlement, ABN AMRO will pay EUR 480 million. ABN AMRO fully cooperated with the DPPS throughout the investigation. Based on the investigation, the DPPS identified serious shortcomings in ABN AMRO's processes to combat money laundering in the Netherlands, such as the client acceptance, transaction monitoring and client exit processes (the so-called 'Client Life Cycle' processes) in the period between 2014 and 2020, as a result of which, in certain instan
Nyxoah Announces Submission of Draft Registration Statement For Proposed Public Listing in the United States19.4.2021 07:02:32 CEST | Press release
REGULATED INFORMATION INSIDE INFORMATION Nyxoah Announces Submission of Draft Registration Statement For Proposed Public Listing in the United States Mont-Saint-Guibert, Belgium – 19 April 2021 – Nyxoah SA (Euronext Brussels: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that it has confidentially submitted a draft Registration Statement on Form F-1 to the Securities and Exchange Commission (the "SEC") relating to the proposed public offering of its ordinary shares in the United States. The number of ordinary shares to be offered and the price for the proposed offering have not yet been determined. The public offering is expected to take place after the SEC completes its review process, subject to market and other conditions. This announcement is being made pursuant to, and in accordance with, Rule 135 under the Securities Act of 1933, as am
Millicom signs agreements to conclude Africa divestiture program19.4.2021 06:05:00 CEST | Press release
Millicomsigns agreements to conclude Africa divestiture program Luxembourg,April19, 2021 – Millicom International Cellular S.A. (“Millicom”) announces that it has signed agreements for the sale of its operations in Tanzania and for its stake in the AirtelTigo joint venture in Ghana. Once closed, the transactions will complete Millicom’s multi-year plan to divest its African operations and focus on its Latin America markets. In Tanzania, Millicom has agreed to sell its entire operations to a consortium led by Axian, a pan-African group that was part of the consortium that acquired Millicom’s operations in Senegal in 2018. In Ghana, Millicom along with its joint venture partner, Bharti Airtel Limited, have signed a definitive agreement for the transfer of AirtelTigo to the Government of Ghana. Millicom will take a $25 million charge as a result of this agreement. Millicom CEO, Mauricio Ramos, commented: “Today Tigo is a leading provider of broadband services to consumers, businesses and
Nokia to deploy indoor 5G small cells solutions with LG Uplus in South Korea19.4.2021 03:00:00 CEST | Press release
Press Release Nokia to deploy indoor 5G small cells solutions with LG Uplus in South Korea Nokia will expand and enhance LG Uplus’ 5G network, enabling seamless 5G connectivity between indoor and outdoor locationsLG Uplus will use Nokia’s AirScale indoor solution which can be deployed flexibly and upgraded easily The deal continues the long-standing partnership between the two companies 19 April 2021 Espoo, Finland – Nokia today announced an agreement with LG Uplus to expand 5G coverage by installing new equipment from Nokia’s comprehensive AirScale portfolio across the country, enabling seamless 5G indoor and outdoor connectivity. The dealis expected to accommodate future network expansion and will further deepen the partnership between the two companies, which have already collaborated on LTE, 5G and digital projects. Being the first deployment of its kind in South Korea, Nokia will install its cost-effective, next-generation small cell AirScale Indoor (ASiR) systems in a range of in